Randomised controlled trials in affective disorders SideindholdWe showed as the first that early intervention in bipolar disorder improves long-term outcome with decreased risk of psychiatric hospitalization and improved adherence to medication and satisfaction with care.We demonstrated in two randomised, placebo-controlled phase II trials that 8 weeks of EPO treatment has mood-independent and enduring beneficial effects on cognition across depression and bipolar disorder.Our group conducted the first randomized, controlled trial of the effects of 12-weeks group-based cognitive remediation treatment on cognitive function in bipolar disorder. The study revealed no beneficial effects on objectively-measured cognitive function (primary trial outcome), although patients reported some improvement in subjective mental sharpness and quality of life. Redaktør Jesper Kvorning For at kunne sende din besked, mangler du at give dit samtykke. Indtast en gyldig e-mail-adresse. Skriv din besked: Indtast din email (skal udfyldes): Jeg giver hermed samtykke til, at Region Hovedstaden behandler oplysningerne i min henvendelse sagligt. Læs betingelserne for dit samtykke Send Der er ikke registreret en emailaddresse for brugeren/gruppen